AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 200 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,042,174 | -73.8% | 262,828 | -67.4% | 0.00% | -76.5% |
| Q2 2023 | $7,797,569 | -45.8% | 805,534 | -38.6% | 0.02% | -52.8% |
| Q1 2023 | $14,383,323 | +624.1% | 1,312,347 | +185.4% | 0.04% | +620.0% |
| Q4 2022 | $1,986,469 | -73.1% | 459,831 | -53.3% | 0.01% | -78.3% |
| Q3 2022 | $7,398,000 | +47.5% | 983,787 | +97.1% | 0.02% | +43.8% |
| Q2 2022 | $5,017,000 | -25.3% | 499,251 | -8.0% | 0.02% | -23.8% |
| Q1 2022 | $6,717,000 | +196.6% | 542,602 | +8.5% | 0.02% | +200.0% |
| Q4 2017 | $2,265,000 | -27.8% | 500,000 | 0.0% | 0.01% | -41.7% |
| Q3 2017 | $3,135,000 | +2.3% | 500,000 | 0.0% | 0.01% | -7.7% |
| Q2 2017 | $3,065,000 | +39.2% | 500,000 | +66.7% | 0.01% | +30.0% |
| Q1 2017 | $2,202,000 | – | 300,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
| ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
| DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
| NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
| Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
| HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
| SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |